Peña Javier, Jiménez Camila, Schmidt Jimena
Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Proyecto Epistemonikos, Santiago, Chile.
Proyecto Epistemonikos, Santiago, Chile; Departamento de Oftalmología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile. Email:
Medwave. 2018 Jan 24;18(1):e7144. doi: 10.5867/medwave.2018.01.7144.
The use of cannabinoids in diverse clinical conditions is today a subject of debate. Its use has been proposed for the control of glaucoma. However, there is controversy about its real effectiveness and safety.
To answer this question we used Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information sources, including MEDLINE, EMBASE, Cochrane, among others. We extracted data from the systematic reviews, reanalyzed data of primary studies and generated a summary of findings table using the GRADE approach.
We identified five systematic reviews including three studies overall, all of them randomized controlled trials. We concluded that although cannabinoids could decrease intraocular pressure, the effect would be transient and associated with frequent adverse effects.
如今,大麻素在多种临床病症中的应用是一个备受争议的话题。有人提议将其用于控制青光眼。然而,对于其实际疗效和安全性存在争议。
为回答这个问题,我们使用了Epistemonikos,这是健康领域最大的系统评价数据库,通过筛选多个信息来源来维护,包括MEDLINE、EMBASE、Cochrane等。我们从系统评价中提取数据,重新分析了原始研究的数据,并使用GRADE方法生成了结果总结表。
我们识别出五项系统评价,总共包括三项研究,均为随机对照试验。我们得出结论,尽管大麻素可以降低眼压,但这种效果是短暂的,且伴有频繁的不良反应。